2009•Jiangsu Medical JournalRequires access

The effect and tolerance with co-administration of nateglinide and insulin glargine in type 2 diabetes

DI Wenjuan

Open publisher page 0 citations

Abstract

Objective To evaluate the effect and tolerance of co-administration of nateglinide and insulin glargine in type 2 diabetes(T2DM).Methods The fasting blood glucose(FBG),postprandial blood glucose(BG),glycosylated hemoglobin(HbA) and the undulation of blood glucose with co-administration of nateglinide and insulin glargine were evaluated in 57 T2DM greater than 60 yrars old.Results Compared to beforetreatment,BG was significantly decreased after co-administration of nateglinide and insulin glargine before breakfast,at 2 hours after lunch and supper and before retiring(P0.05),which was more at 2 hours after breakfast and before lunch(P0.01).There was a tendency of decrease in BG before supper and at 3 AM in the early morning(P0.05).Conclusion Nateglinide combined with insulin glargine can be used effectively and safely to treat T2DM patients aged greater than 60 yrars old.

About this research paper

What this paper is about

Objective To evaluate the effect and tolerance of co-administration of nateglinide and insulin glargine in type 2 diabetes(T2DM).Methods The fasting blood glucose(FBG),postprandial blood glucose(BG),glycosylated hemoglobin(HbA) and the undulation of blood glucose with co-administration of nateglinide and insulin glargine were evaluated in 57 T2DM greater than 60 yrars old.Results Compared to beforetreatment,BG was significantly decreased after co-administration of nateglinide and insulin glargine before breakfast,at 2 hours after lunch and supper and before retiring(P0.05),which was more at 2 hours after breakfast and before lunch(P0.01).There was a tendency of decrease in BG before supper and at 3 AM in the early morning(P0.05).Conclusion Nateglinide combined with insulin glargine can be used effectively and safely to treat T2DM patients aged greater than 60 yrars old.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effect and tolerance of co-administration of nateglinide and insulin glargine in type 2 diabetes(T2DM).Methods The fasting blood glucose(FBG),postprandial blood glucose(BG),glycosylated hemoglobin(HbA) and the undulation of blood glucose with co-administration of nateglinide and insulin glargine were evaluated in 57 T2DM greater than 60 yrars old.Results Compared to beforetreatment,BG was significantly decreased after co-administration of nateglinide and insulin glargine before breakfast,at 2 hours after lunch and supper and before retiring(P0.05),which was more at 2 hours after breakfast and before lunch(P0.01).There was a tendency of decrease in BG before supper and at 3 AM in the early morning(P0.05).Conclusion Nateglinide combined with insulin glargine can be used effectively and safely to treat T2DM patients aged greater than 60 yrars old.

Key concepts: Nateglinide, Medicine, Insulin glargine, Postprandial, Type 2 diabetes, Internal medicine, Morning, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
The effect and tolerance with co-administration of nateglinide and insulin glargine in type 2 diabetes — Research Paper | ScholarLens